In 2005, Anna Shalimova graduated from Kharkiv National Medical University, Ukraine. In 2010, she defended her PhD thesis on ‘The mechanisms of development of chronic heart failure at chronic kidney disease’ and in 2016, she defended her Doctoral thesis on ‘The role of genetic, cardiac hemodynamic and metabolic mechanisms in the development of comorbid pathology – essential hypertension and type 2 diabetes’.
In 2017-2018, she worked as a postdoc at the Department of Hypertension and Diabetology in Medical University of Gdansk.
Current Position: Kharkiv National Medical University, Professor; Government Institution ‘L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine’, Leading researcher.
Scientific interests: risk factors of chronic non-communicable diseases, genetic markers of development and progression of arterial hypertension and diabetes mellitus, methods of primary and secondary prevention of chronic non-communicable diseases.
Association of genetic polymorphism of TCF7L2 with the severity of cardiac remodeling and adipokines disbalance in comorbidity of essential hypertension and type 2 diabetes
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: co-morbidities (other)
Session: Comorbodities
